drug development

FDA moves to ease path for biosimilars as Trump seeks to cut drug costs statnews.comHHS Sec. Robert F. Kennedy…

In this week’s edition of InnovationRx, we look at President Trump’s cognitive test, Nvidia’s collaborations in life sciences…

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. ~*~*~Don’t talk to…

aTyr Pharma (Nasdaq: ATYR) announced topline results from its Phase…

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…

Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. This is the…

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…

I asked AI the other day how many biotechs have been co-founded by Harvard’s George Church. About 50…

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…

FDA moves to ease path for biosimilars as Trump seeks to cut drug costs – statnews.com